{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T03:56:43Z","timestamp":1786247803686,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.genhosppsych.2007.09.003","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T07:43:02Z","timestamp":1208763782000},"page":"280-283","source":"Crossref","is-referenced-by-count":28,"title":["Beta-blocker and angiotensin-converting enzyme inhibitor may limit certain cardiac adverse effects of clozapine"],"prefix":"10.1016","volume":"30","author":[{"given":"Carlo","family":"Rostagno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Di Norscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Framco","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Gensini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2007.09.003_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.321.7273.1360","article-title":"Atypical antipsychotics. Patients value the lower incidence of extrapiramidal side effects","volume":"321","author":"Kapur","year":"2000","journal-title":"BMJ"},{"issue":"Suppl 9","key":"10.1016\/j.genhosppsych.2007.09.003_bib4","first-page":"35","article-title":"Treatment-resistant schizophrenic patients","volume":"57","author":"Kane","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.jcp.0000150217.51433.9f","article-title":"Adverse cardiac effects associated with clozapine","volume":"25","author":"Merril","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib6","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Killian","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib7","first-page":"4151","article-title":"Allergic myocarditis in clozapine treatment","volume":"156","author":"Jensen","year":"1994","journal-title":"Ugeskrift for Laeger"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/j.1440-1614.2004.01481.x","article-title":"Clozapine related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service","volume":"38","author":"Reinders","year":"2004","journal-title":"Austr NZ Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM200107193450317","article-title":"Myocarditis and cardiomyopathy associated with clozapine in the United States","volume":"345","author":"La Grenade","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/1044546041648977","article-title":"Chart review for potential features of myocarditis in children and adolescents treated with clozapine","volume":"14","author":"Wehemeier","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib12","first-page":"9","article-title":"Myocarditis and cardiomyopathy with antipsychotics: recent cases with clozapine (Clozaril)","volume":"19","author":"Committee on Safety of Medicine","year":"1999","journal-title":"Currr Probl Pharmacovigilance"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/106002809603000606","article-title":"Cardiomyopathy associated with clozapine","volume":"30","author":"Leo","year":"1996","journal-title":"An Pharmacother"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib14","unstructured":"Novartis Pharma Canada. Association of Clozaril (clozapine) with cardiovascular toxicity [Dear healthcare professional letter] 2002. Available at: http:\/\/www.hc-sc-gc-ca\/hpfb-dgpsa\/tdp-dpt\/clozaril_e.pdf."},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2710.2004.00616_1.x","article-title":"Myocarditis and cardiomyopathy in patients treated with clozapine","volume":"30","author":"Wehemeier","year":"2005","journal-title":"J Clin Pharmacol Ther"},{"key":"10.1016\/j.genhosppsych.2007.09.003_bib16","first-page":"167","article-title":"Association of autonomic dysfunction and clozapine heart rate variability and risk of sudden death in patients with schizophrenia on long-term psychotropic medications","volume":"179","author":"Cohen","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2007.09.003_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8159.1996.tb04796.x","article-title":"Tachycardiomyopathy: mechanisms and clinical implications","volume":"19","author":"Fenelon","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2007.09.003_bib18","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1136\/hrt.2003.017129","article-title":"Tachycardiomyopathy: a diagnosis not to be missed","volume":"90","author":"Walker","year":"2004","journal-title":"Heart"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834307001867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834307001867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T11:22:28Z","timestamp":1557487348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834307001867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0163834307001867"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2007.09.003","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}